InvestorsHub Logo
Followers 0
Posts 186
Boards Moderated 0
Alias Born 10/25/2010

Re: neuroinv post# 35316

Wednesday, 01/05/2011 3:10:17 PM

Wednesday, January 05, 2011 3:10:17 PM

Post# of 47402
I'd like to thank you for the always thoughtful, and informed posts you provide our board. While I agree that not much thought has gone into posts speculating on why there has been a delay in SA data, and agree the two events you mentioned (termination of Biovail's RD agreement, Servier's announcement of an H.I. ampakine entering phase I) would both provide some justification for not releasing data since they could most certainly affect ongoing negotiations regarding partnerships, financings or sale of the company, there still remains among many the belief that due to a history of missed deadlines, and the poor communication with shareholders that whatever rational is provided, in the absence of significant S.P. appreciation, those excuses simply will not be sufficient.
Steve Jobs can get away with hiding the true nature of his health, and can even backdate options without offending shareholders, or even incurring inordinate SEC wrath. I suspect one of the reasons he can do so with impunity is Apple stock appreciation under his leadership.
Perhaps it is crass to bring up such non-CORX related analogies, but I think management has created an environment that will call for justifications in suppressing SA results that exceed those for the delay in RD (due to vacationing Germans), NASDAC delisting, or the missed 30 day timeline for an RD deal provided to us last fall.
Should they fail to do so, it can only serve to make some posters even more lazy in their continued criticism of management.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News